Inaugural Asia Summit on Global Health held tomorrow in hybrid format
Capturing new opportunities in Asia’s healthcare industry
23 November 2021 – Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (ASGH) will take place tomorrow, 24 November, at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format, offering both online and in-person participation. Running on the theme “Shaping a Resilient and Sustainable Future”, the summit aims at building an international investment and business exchange platform to promote dialogue and collaboration between the biotech, medical and healthcare sectors in Hong Kong, Mainland China and across the globe, and to explore investment opportunities. The summit will also highlight Hong Kong’s advantages as a scientific research and business platform for the medical and healthcare sectors.
More than 70 speakers from around the world, including senior government officials, investors, influential business leaders, financial and professional service providers, as well as renowned academics from related sectors, will participate in the event online or in person. Carrie Lam, Chief Executive of the HKSAR, Dr Peter K N Lam, Chairman of the HKTDC, and Dr Soumya Swaminathan, Chief Scientist, World Health Organization (WHO), will address the Opening Session. This will be followed by the Plenary Session chaired by First Eastern Investment Group (Hong Kong) and featuring renowned speakers from Fosun International Limited, Primavera Capital Group, the Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong, and AstraZeneca.
The summit will cover a number of forward-looking topics, including the latest developments in healthtech, biotechnology and digital health, the prospects for the healthcare industry in China (particularly the Greater Bay Area), the Association of Southeast Asian Nations (ASEAN) bloc and other Asian nations, as well as Hong Kong's advantages as a biotech listing hub. This will help industry participants to explore business opportunities and options in sustainable development.
Other key features of the summit are Deal Flow Matchmaking for healthcare projects and investors, the InnoHealth Showcase and Exhibition, which will present cutting-edge technologies from about 100 start-ups and international projects, healthcare enterprises and related organisations, and various other activities, both online and onsite, to encourage business exchange and collaboration among the global participants.
We cordially invite you or your representatives to attend the inaugural Asia Summit on Global Health. Details are as follows:
Date |
24 November 2021 (Wednesday) |
Time |
Opening Session begins at 9am (Hong Kong time) |
Venue Press registration counter Media Centre |
Convention Hall, HKCEC Entrance of Convention Hall, HKCEC (through the escalator near The Atrium Chinese Restaurant) Room S227, HKCEC |
Websites |
ASGH website: https://www.asiasummitglobalhealth.com/en/ Programme: https://www.asiasummitglobalhealth.com/en/programme/programme Speakers: https://www.asiasummitglobalhealth.com/en/speaker/speakers |
Please note:
***********************Media Online Registration Form for ASGH***********************
(All fields are compulsory)
|
Salutation |
Given name |
Surname |
Company |
Position |
Country / region |
|
|
|
|
|
|
|
Speakers at the summit include (in alphabetical order according to family name):
Bernard Charnwut Chan, President, Asia Financial Holdings Limited |
Margaret Chan, Founding Dean, Vanke School of Public Health, Tsinghua University; Emeritus Director-General, World Health Organization |
Chen Qiyu, Executive Director and Co-CEO, Fosun International Limited |
Cheng Cheung Ling*, Vice Chairlady, Sino Biopharmaceutical Limited |
Victor Chu*, Chairman & CEO, First Eastern Investment Group |
Steve Davis, Senior Strategy Advisor and Interim Director, China Country Office, Bill & Melinda Gates Foundation |
Claudia Süessmuth Dyckerhoff*, Board member of Hoffmann-La Roche; Board Member of Ramsay Health Care |
Sandro Galea, Dean and Robert A Knox Professor, Boston University School of Public Health |
Antony Leung, Group Chairman & CEO, Nan Fung Group; Group Chairman & Co-Founder, New Frontier Group |
Nisa Leung, Managing Partner, Qiming Venture Partners |
Jieyuan Liao, Founder, Chairman and CEO, We Doctor (HK) Limited |
Chung-Mau Lo*, Hospital Chief Executive, The University of Hong Kong-Shenzhen Hospital |
Dennis Lo*, Director and Li Ka Shing Professor of Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong |
Sir Michael Marmot, Director of the Institute of Health Equity, Department of Epidemiology & Public Health, University College London |
Ma Xiaowei, Minister for National Health Commission of the People’s Republic of China |
Abrar Mir, Co-founder and Managing Partner, Quadria Capital |
Nachman Ash, Director-General and Ministry of Health, Israel |
Per Vegard Nerseth, Chief Executive Officer, CMR Surgical |
Ruchira Shukla, South Asia Regional Lead for Disruptive Technology Investments, International Finance Corporation (IFC) World Bank Group |
Soumya Swaminathan, Chief Scientist, World Health Organization |
Rocky Tuan*, Vice-Chancellor and President, The Chinese University of Hong Kong |
Leon Wang, Executive Vice President, International and China President, AstraZeneca |
Michelle Williams, Dean of the Faculty, Harvard TH Chan School of Public Health |
|
*Will attend in person
Media enquiries
Please contact the HKTDC’s Communication and Public Affairs Department:
Sunny Ng Tel: (852) 2584 4357 Email: sunny.sl.ng@hktdc.org
Sam Ho Tel: (852) 2584 4569 Email: sam.sy.ho@hktdc.org
Yuan Tung Financial Relations:
Agnes Yiu Tel: (852) 3428 5690 Email: ayiu@yuantung.com.hk
Hing-fung Wong Tel: (852) 3428 3122 Email: hfwong@yuantung.com.hk